{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:24:57Z","timestamp":1785540297171,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"DOI":"10.7759\/cureus.102162","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:25:22Z","timestamp":1769192722000},"source":"Crossref","is-referenced-by-count":2,"title":["Azathioprine-Associated Acute Pancreatitis Followed by a Probable Autoimmune Hepatitis Flare After Thiopurine Withdrawal: A Case Report"],"prefix":"10.7759","author":[{"given":"Emmanuel","family":"Marfo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Oladoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31829f16fc","article-title":"Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease?","volume":"57","author":"Ledder OD","year":"2013","unstructured":"Ledder OD, Lemberg DA, Ooi CY, Day AS. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease?. J Pediatr Gastroenterol Nutr. 2013, 57:583-6. 10.1097\/MPG.0b013e31829f16fc","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002012","article-title":"Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel disease","volume":"51","author":"Freitas M","year":"2022","unstructured":"Freitas M, Lima Capela T, Macedo Silva V, et al.. Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. Pancreas. 2022, 51:288-94. 10.1097\/MPA.0000000000002012","journal-title":"Pancreas"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(18)30401-2","article-title":"Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study","volume":"3","author":"Wintzell V","year":"2019","unstructured":"Wintzell V, Svanstr\u00f6m H, Ol\u00e9n O, Melbye M, Ludvigsson JF, Pasternak B. Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish-Danish nationwide cohort study. Lancet Child Adolesc Health. 2019, 3:158-65. 10.1016\/S2352-4642(18)30401-2","journal-title":"Lancet Child Adolesc Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03746.x","article-title":"Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis","volume":"28","author":"Bermejo F","year":"2008","unstructured":"Bermejo F, Lopez-Sanroman A, Taxonera C, et al.. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008, 28:623-8. 10.1111\/j.1365-2036.2008.03746.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001914","article-title":"Frequency, predisposing factors, and clinical outcome of azathioprine-induced pancreatitis among patients with inflammatory bowel disease: results from a tertiary referral center","volume":"50","author":"Eskazan T","year":"2021","unstructured":"Eskazan T, Bozcan S, Atay K, et al.. Frequency, predisposing factors, and clinical outcome of azathioprine-induced pancreatitis among patients with inflammatory bowel disease: results from a tertiary referral center. Pancreas. 2021, 50:1274-80. 10.1097\/MPA.0000000000001914","journal-title":"Pancreas"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv086","article-title":"Successful mercaptopurine usage despite azathioprine-induced pancreatitis in paediatric Crohn\u2019s disease","volume":"9","author":"Gallego-Guti\u00e9rrez S","year":"2015","unstructured":"Gallego-Guti\u00e9rrez S, Navas-L\u00f3pez VM, Kolorz M, et al.. Successful mercaptopurine usage despite azathioprine-induced pancreatitis in paediatric Crohn\u2019s disease. J Crohns Colitis. 2015, 9:676-9. 10.1093\/ecco-jcc\/jjv086","journal-title":"J Crohns Colitis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14483","article-title":"HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease","volume":"47","author":"Wilson A","year":"2018","unstructured":"Wilson A, Jansen LE, Rose RV, et al.. HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2018, 47:615-20. 10.1111\/apt.14483","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3093","article-title":"HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants","volume":"46","author":"Heap GA","year":"2014","unstructured":"Heap GA, Weedon MN, Bewshea CM, et al.. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat Genet. 2014, 46:1131-4. 10.1038\/ng.3093","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003465","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults","volume":"120","author":"Lichtenstein GR","year":"2025","unstructured":"Lichtenstein GR, Loftus EV, Afzali A, Long MD, Barnes EL, Isaacs KL, Ha CY. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2025, 120:1225-64. 10.14309\/ajg.0000000000003465","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.09.038","article-title":"AGA Living Clinical Practice Guideline on the pharmacologic management of moderate-to-severe Crohn\u2019s disease","volume":"169","author":"Scott FI","year":"2025","unstructured":"Scott FI, Ananthakrishnan AN, Click B, et al.. AGA Living Clinical Practice Guideline on the pharmacologic management of moderate-to-severe Crohn\u2019s disease. Gastroenterology. 2025, 169:1397-448. 10.1053\/j.gastro.2025.09.038","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack CL","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, et al.. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020, 72:671-722. 10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan MA","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013, 382:1433-44. 10.1016\/S0140-6736(12)62163-1","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001492","article-title":"Hepatic issues and complications associated with inflammatory bowel disease: a clinical report from the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees","volume":"64","author":"Saubermann LJ","year":"2017","unstructured":"Saubermann LJ, Deneau M, Falcone RA, et al.. Hepatic issues and complications associated with inflammatory bowel disease: a clinical report from the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr. 2017, 64:639-52. 10.1097\/MPG.0000000000001492","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746030-00001","article-title":"Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing","volume":"46","author":"Teml A","year":"2007","unstructured":"Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet. 2007, 46:187-208. 10.2165\/00003088-200746030-00001","journal-title":"Clin Pharmacokinet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2023.06.003","article-title":"Drug-induced acute pancreatitis due to medications used for inflammatory bowel disease: a VigiBase pharmacovigilance database study","volume":"23","author":"Lee AA","year":"2023","unstructured":"Lee AA, Gupta S, Labban M, Cao FT, Trinh QD, McNabb-Baltar J. Drug-induced acute pancreatitis due to medications used for inflammatory bowel disease: a VigiBase pharmacovigilance database study. Pancreatology. 2023, 23:569-73. 10.1016\/j.pan.2023.06.003","journal-title":"Pancreatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv188","article-title":"Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases - a prospective study on incidence and severity","volume":"10","author":"Teich N","year":"2016","unstructured":"Teich N, Mohl W, Bokemeyer B, et al.. Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases - a prospective study on incidence and severity. J Crohns Colitis. 2016, 10:61-8. 10.1093\/ecco-jcc\/jjv188","journal-title":"J Crohns Colitis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456183-azathioprine-associated-acute-pancreatitis-followed-by-a-probable-autoimmune-hepatitis-flare-after-thiopurine-withdrawal-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:25:22Z","timestamp":1769192722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456183-azathioprine-associated-acute-pancreatitis-followed-by-a-probable-autoimmune-hepatitis-flare-after-thiopurine-withdrawal-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.102162","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}